AstraZeneca's Crestor cuts death, heart attack
NEW ORLEANS (Reuters) - AstraZeneca's cholesterol fighter Crestor dramatically cut deaths, heart attacks and strokes in patients with healthy cholesterol levels but who had high levels of a protein associated with heart disease, researchers said on Sunday.</p><div class="feedflare">
<img src="http://feedproxy.google.com/~f/reuters/healthNews?d=41" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=IIE8NLKw) <img src="http://feedproxy.google.com/~f/reuters/healthNews?i=y6XLw1wa" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=y6XLw1wa) <img src="http://feedproxy.google.com/~f/reuters/healthNews?i=YYUF1PXI" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=YYUF1PXI)
</div><img src="http://feedproxy.google.com/~r/reuters/healthNews/~4/ChQ92Zt2SqI" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/healthNews/~3/ChQ92Zt2SqI/idUSTRE4A81LH20081109